# Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines

> **NCT00514189** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 2 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** Autologous Dendritic Cells

## Key facts

- **NCT ID:** NCT00514189
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Terminated early due to slow accrual.
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514189, "Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00514189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*